The United States Food and Drug Administration (USFDA) announced today that IBM, KPMG, Merck and Walmart will be included in a pilot project in support of the U.S. Drug Supply Chain Security Act (DSCSA). The DSCSA pilot is intended to assist drug supply chain stakeholders, including the FDA, in developing the technology that will identify and trace certain prescription drugs.
Read in Full
CoinMarkets is an automated news aggregation service. All copyrights belong to their respective owners. Images and text owned by copyright holders are used in reference to and promotion of those respective parties.
While the DSCSA pilot will trace various vaccines and prescription medicines from Merck, each company involved brings unique expertise to the project, as well as prior experience in implementing blockchain solutions to enhance the safety and traceability of products. Transparency Is Key
And while there are other ways to trace and track products without using blockchain technology, Mark Treshock, IBM Global Solutions Leader for Blockchain in Healthcare Life Sciences, points out that blockchain is the ideal application for this pilot due to the high-level of transparency it provides.